Search

everythinglearnresearchcommunity

for

Search:↓

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

The protein EZH2 blocks microRNA-22, increasing STK40 protein, which helps hair follicle stem cells change and grow hair.

Baicalin may help reduce excessive male hormone levels in PCOS.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

The Bcl-2 protein is important for keeping hair follicle stem cells working and preventing hair loss.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Thy-1 protein helps improve blood flow and wound healing in the skin.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Genes affecting wool fiber thickness in Angora rabbits were identified, which could help breed finer wool.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Setipiprant did not significantly improve hair growth in men with hair loss.